Literature DB >> 18229454

Functioning of the Hsp90 machine in chaperoning checkpoint kinase I (Chk1) and the progesterone receptor (PR).

Sara J Felts1, Larry M Karnitz, David O Toft.   

Abstract

Hsp90 is an abundant and highly conserved chaperone that functions at later stages of protein folding to maintain and regulate the activity of client proteins. Using a recently described in vitro system to fold a functional model kinase Chk1, we performed a side-by-side comparison of the Hsp90-dependent chaperoning of Chk1 to that of the progesterone receptor (PR) and show that these distinct types of clients have different chaperoning requirements. The less stable PR required more total chaperone protein(s) and p23, whereas Chk1 folding was critically dependent on Cdc37. When the 2 clients were reconstituted under identical conditions, each client folding was dose dependent for Hsp90 protein levels and was inhibited by geldanamycin. Using this tractable system, we found that Chk1 kinase folding was more effective if we used a type II Hsp40 cochaperone, whereas PR is chaperoned equally well with a type I or type II Hsp40. Additional dissection of Chk1-chaperone complexes and the resulting kinase activity suggests that kinase folding, like that previously shown for PR, is a dynamic, multistep process. Importantly, the cochaperones Hop and Cdc37 cooperate as the kinase transitions from immature Hsp70- to mature Hsp90-predominant complexes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18229454      PMCID: PMC2134797          DOI: 10.1379/csc-299.1

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  46 in total

1.  The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37).

Authors:  S Mark Roe; Maruf M U Ali; Philippe Meyer; Cara K Vaughan; Barry Panaretou; Peter W Piper; Chrisostomos Prodromou; Laurence H Pearl
Journal:  Cell       Date:  2004-01-09       Impact factor: 41.582

Review 2.  Emerging Hsp90 inhibitors: from discovery to clinic.

Authors:  G Chiosis; A Rodina; K Moulick
Journal:  Anticancer Agents Med Chem       Date:  2006-01       Impact factor: 2.505

3.  HSP40 binding is the first step in the HSP90 chaperoning pathway for the progesterone receptor.

Authors:  M Patricia Hernández; Ahmed Chadli; David O Toft
Journal:  J Biol Chem       Date:  2002-01-23       Impact factor: 5.157

4.  p50(cdc37) is a nonexclusive Hsp90 cohort which participates intimately in Hsp90-mediated folding of immature kinase molecules.

Authors:  S D Hartson; A D Irwin; J Shao; B T Scroggins; L Volk; W Huang; R L Matts
Journal:  Biochemistry       Date:  2000-06-27       Impact factor: 3.162

5.  Regulation of Hsp90 ATPase activity by the co-chaperone Cdc37p/p50cdc37.

Authors:  Giuliano Siligardi; Barry Panaretou; Philippe Meyer; Shradha Singh; Derek N Woolfson; Peter W Piper; Laurence H Pearl; Chrisostomos Prodromou
Journal:  J Biol Chem       Date:  2002-03-26       Impact factor: 5.157

6.  Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4.

Authors:  L Stepanova; X Leng; S B Parker; J W Harper
Journal:  Genes Dev       Date:  1996-06-15       Impact factor: 11.361

7.  Hsp90 regulates p50(cdc37) function during the biogenesis of the activeconformation of the heme-regulated eIF2 alpha kinase.

Authors:  J Shao; N Grammatikakis; B T Scroggins; S Uma; W Huang; J J Chen; S D Hartson; R L Matts
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

8.  Ligand discrimination by TPR domains. Relevance and selectivity of EEVD-recognition in Hsp70 x Hop x Hsp90 complexes.

Authors:  Achim Brinker; Clemens Scheufler; Florian Von Der Mulbe; Burkhard Fleckenstein; Christian Herrmann; Gunther Jung; Ismail Moarefi; F Ulrich Hartl
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

9.  SBA1 encodes a yeast hsp90 cochaperone that is homologous to vertebrate p23 proteins.

Authors:  Y Fang; A E Fliss; J Rao; A J Caplan
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

Review 10.  Hsp90: a specialized but essential protein-folding tool.

Authors:  J C Young; I Moarefi; F U Hartl
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

View more
  13 in total

1.  Plasticity of the Hsp90 chaperone machine in divergent eukaryotic organisms.

Authors:  Jill L Johnson; Celeste Brown
Journal:  Cell Stress Chaperones       Date:  2008-07-18       Impact factor: 3.667

2.  Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis.

Authors:  Chaitanya A Patwardhan; Abdul Fauq; Laura B Peterson; Charles Miller; Brian S J Blagg; Ahmed Chadli
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

3.  Celastrol inhibits Hsp90 chaperoning of steroid receptors by inducing fibrillization of the Co-chaperone p23.

Authors:  Ahmed Chadli; Sara J Felts; Qin Wang; William P Sullivan; Maria Victoria Botuyan; Abdul Fauq; Marina Ramirez-Alvarado; Georges Mer
Journal:  J Biol Chem       Date:  2009-12-08       Impact factor: 5.157

4.  Biochemical reconstitution of steroid receptor•Hsp90 protein complexes and reactivation of ligand binding.

Authors:  Patrick J M Murphy; Hannah R Franklin; Nathan W Furukawa
Journal:  J Vis Exp       Date:  2011-09-21       Impact factor: 1.355

Review 5.  Conformational dynamics of the molecular chaperone Hsp90.

Authors:  Kristin A Krukenberg; Timothy O Street; Laura A Lavery; David A Agard
Journal:  Q Rev Biophys       Date:  2011-03-18       Impact factor: 5.318

6.  C1206, a novel curcumin derivative, potently inhibits Hsp90 and human chronic myeloid leukemia cells in vitro.

Authors:  Ying-Juan Fan; Yi-Xiang Zhou; Lian-Ru Zhang; Qiao-Fa Lin; Ping-Zhang Gao; Fang Cai; Li-Ping Zhu; Bi Liu; Jian-Hua Xu
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

Review 7.  Hsp90 and co-chaperones twist the functions of diverse client proteins.

Authors:  Abbey Zuehlke; Jill L Johnson
Journal:  Biopolymers       Date:  2010-03       Impact factor: 2.505

8.  Ydj1 protects nascent protein kinases from degradation and controls the rate of their maturation.

Authors:  Atin K Mandal; Nadinath B Nillegoda; Jennifer A Chen; Avrom J Caplan
Journal:  Mol Cell Biol       Date:  2008-04-28       Impact factor: 4.272

Review 9.  The therapeutic target Hsp90 and cancer hallmarks.

Authors:  Yoshihiko Miyata; Hitoshi Nakamoto; Len Neckers
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  Nox5 stability and superoxide production is regulated by C-terminal binding of Hsp90 and CO-chaperones.

Authors:  Feng Chen; Steven Haigh; Yanfang Yu; Tyler Benson; Yusi Wang; Xueyi Li; Huijuan Dou; Zsolt Bagi; Alexander D Verin; David W Stepp; Gabor Csanyi; Ahmed Chadli; Neal L Weintraub; Susan M E Smith; David J R Fulton
Journal:  Free Radic Biol Med       Date:  2015-10-09       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.